1ce8: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:1ce8.jpg|left|200px]] | [[Image:1ce8.jpg|left|200px]] | ||
<!-- | |||
The line below this paragraph, containing "STRUCTURE_1ce8", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
| | --> | ||
| | {{STRUCTURE_1ce8| PDB=1ce8 | SCENE= }} | ||
}} | |||
'''CARBAMOYL PHOSPHATE SYNTHETASE FROM ESCHERICHIS COLI WITH COMPLEXED WITH THE ALLOSTERIC LIGAND IMP''' | '''CARBAMOYL PHOSPHATE SYNTHETASE FROM ESCHERICHIS COLI WITH COMPLEXED WITH THE ALLOSTERIC LIGAND IMP''' | ||
Line 23: | Line 20: | ||
==Reference== | ==Reference== | ||
The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase., Thoden JB, Raushel FM, Wesenberg G, Holden HM, J Biol Chem. 1999 Aug 6;274(32):22502-7. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10428826 10428826] | The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase., Thoden JB, Raushel FM, Wesenberg G, Holden HM, J Biol Chem. 1999 Aug 6;274(32):22502-7. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10428826 10428826] | ||
[[Category: Escherichia coli]] | [[Category: Escherichia coli]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
Line 29: | Line 25: | ||
[[Category: Raushel, F M.]] | [[Category: Raushel, F M.]] | ||
[[Category: Thoden, J B.]] | [[Category: Thoden, J B.]] | ||
[[Category: | [[Category: Allosteric ligand]] | ||
[[Category: | [[Category: Imp]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 12:37:57 2008'' | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on |
Revision as of 12:37, 2 May 2008
CARBAMOYL PHOSPHATE SYNTHETASE FROM ESCHERICHIS COLI WITH COMPLEXED WITH THE ALLOSTERIC LIGAND IMP
OverviewOverview
Carbamoyl phosphate synthetase (CPS) from Escherichia coli catalyzes the formation of carbamoyl phosphate, which is subsequently employed in both the pyrimidine and arginine biosynthetic pathways. The reaction mechanism is known to proceed through at least three highly reactive intermediates: ammonia, carboxyphosphate, and carbamate. In keeping with the fact that the product of CPS is utilized in two competing metabolic pathways, the enzyme is highly regulated by a variety of effector molecules including potassium and ornithine, which function as activators, and UMP, which acts as an inhibitor. IMP is also known to bind to CPS but the actual effect of this ligand on the activity of the enzyme is dependent upon both temperature and assay conditions. Here we describe the three-dimensional architecture of CPS with bound IMP determined and refined to 2.1 A resolution. The nucleotide is situated at the C-terminal portion of a five-stranded parallel beta-sheet in the allosteric domain formed by Ser(937) to Lys(1073). Those amino acid side chains responsible for anchoring the nucleotide to the polypeptide chain include Lys(954), Thr(974), Thr(977), Lys(993), Asn(1015), and Thr(1017). A series of hydrogen bonds connect the IMP-binding pocket to the active site of the large subunit known to function in the phosphorylation of the unstable intermediate, carbamate. This structural analysis reveals, for the first time, the detailed manner in which CPS accommodates nucleotide monophosphate effector molecules within the allosteric domain.
About this StructureAbout this Structure
1CE8 is a Protein complex structure of sequences from Escherichia coli. Full crystallographic information is available from OCA.
ReferenceReference
The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase., Thoden JB, Raushel FM, Wesenberg G, Holden HM, J Biol Chem. 1999 Aug 6;274(32):22502-7. PMID:10428826 Page seeded by OCA on Fri May 2 12:37:57 2008